For more questions, please click "Consult Now", a professional consultant will answer your questions.
Shanghai Pharmacies Medical & Biotechnology Co., Ltd. is a professional SMO company (SMO means site management organization). Founded in 2011, our company is located in Zhangjiang Hi-TechPark, Pudong, Shanghai. The founding team members and the company's technicians graduated from well-known universities at home and abroad with extensive clinical practical experience and management experience. We aim to provide professional services for clinical trials, assist researchers and research institutions in non-medical judgmental clinical work, improve the quality and progress of clinical trials and promote the standardization of clinical trials.
The Clinical Coordination Department in Pharmacies established offices in more than 40 cities over the years, such as East China, South China, Central China, North China and Southwest China in Shanghai, Beijing, Guangzhou, Zhengzhou, Changsha, Harbin, Hangzhou, Wenzhou, Haikou, Xining, Kunming, Chongqing and Chengdu with nearly 200 CRC personnel. Following the ICH-GCP and the medical ethical principle of Helsinki Declaration, Pharmacies has established an international standard operating procedure (SOP).
Over the years, the SMO Department has promoted development with high-quality. We firmly believe that quality is the concept of life. With fair price and efficient service, we have established long-term strategic partnership with our customers. Pharmacies have been highly recognized in the industry.
To be continued.... |
Pharmacies has participated in more than 300 projects, about 60 multi-center clinical studies and more than 200 research centers participating in the service. The majors involved are clinical, oncology, endocrinology, cardiovascular,respiratory, digestive, neuropsychiatric and infectious diseases, pediatrics, ophthalmology, orthopedics.
Pharmacies’ project covers various fields such as traditional Chinese medicine, chemical medicine, biological products, medical equipment, diagnostic reagents, etc. In recent years, multi-center clinical equipment projects have been increasing year by year and a relatively mature phase I clinical research service system has been formed.
Examples of multi-center projects by early 2020
Indication | Project Type | Project Stage | Number of Centers |
Type 2 diabetes | Chemical Medicine | Stage IV | >20 |
Aged unstable angina | Chinese Medicine | Stage IV | >25 |
Cerebral infarction | Chemical Medicine | Stage IV | >10 |
Anemia due to chemotherapy for non-bone malignant tumors | Biological Product | Stage Ⅱ | >15 |
Aortic dissection | Instrument | Stage Ⅲ | >15 |
Anemia due to chemotherapy for non-bone malignant tumors | Biological product | Stage Ⅱ | >10 |
Anemia due to chemotherapy for non-bone malignant tumors | Biological product | Stage Ⅱ | >10 |
Peptic ulcer | Chemical Medicine | Stage Ⅱ | >10 |
Knee osteoarthritis | Chinese Medicine | Stage Ⅱ | >5 |
Myelody splastic syndrome | Chemical Medicine | Stage IV | >5 |
Multi-drug resistant pulmonary tuberculosis with positive sputum culture | Chemical Medicine | Stage IV | >25 |
thrombosis | Instrument | Stage Ⅲ | >20 |
Anemia due to chemotherapy for non-bone malignant tumors | Biological product | Stage Ⅱ | >5 |
Oral ulcer | Chinese Medicine | Stage IV | >5 |
Primary glaucoma | Instrument | Stage Ⅲ | >5 |
Chronic hepatitis B | Chemical Medicine | Stage Ⅱ | >15 |
Thalassemia pregnant women | Chinese Medicine | Stage IV | >5 |
common cold | Chinese Medicine | Stage Ⅱ | >5 |
Rheumatoid arthritis | Chinese Medicine | Stage Ⅱ | >10 |
Peptic ulcer bleeding | Chemical Medicine | Stage Ⅲ | >5 |
Duodenal ulcer | Chemical Medicine | Stage Ⅲ | >10 |
Duodenal ulcer | Chemical Medicine | Stage Ⅲ | >5 |
Intracranial cerebral aneurysm | Instrument | Stage Ⅲ | >10 |
Acute exacerbation of chronic obstructive pulmonary disease | Instrument | Stage Ⅲ | >10 |
|
|
|
|